| Fact Table | |
|---|---|
| Formula | C20H34O5 |
| License | FDA approved; Initial U.S. approval: 1981 |
| Bioavailability | Absolute bioavailability not determined (intracavernosal use) |
| Legal status | Prescription only (Rx) |
| Chemical Name | (11a,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid |
| Elimination half-life | Approximately 9–11 minutes; short biological half-life |
| Dosage (Strength) | 20 mcg/vial and 40 mcg/vial lyophilized powder for reconstitution; intracavernosal dose individually titrated |
| Pregnancy | Not indicated for use in women; pregnancy data not applicable for this product |
| Brands | Caverject |
| Protein binding | Primarily to albumin (81%); also a-globulin IV-4 fraction (55%) |
| PubChem CID | 5280723 |
| MedlinePlus | a695022 |
| ChEBI | 15544 |
| ATC code | G04BE01 |
| DrugBank | DB00770 |
| KEGG | D00180 |
| Routes of administration | Intracavernosal injection (after reconstitution) |
Caverject contains alprostadil, a synthetic form of prostaglandin E1, used to treat erectile dysfunction in men. It works by relaxing smooth muscle tissue and widening blood vessels in the penis. This allows increased blood flow to help achieve and maintain an erection. The medication comes as a sterile powder that's mixed and injected directly into the side of the penis.
Caverject is given via intracavernosal injection, meaning it's injected directly into the side of the penis. A healthcare provider should demonstrate the proper preparation and injection technique before attempting self-administration.
The medication comes as a powder that must be mixed with sterile water before use. The typical starting dose is 2.5 to 5 mcg, which a doctor may adjust based on how well it works. Do not use more than one injection per day or more than three times per week.
Each vial, syringe, and needle is for single use only and should be thrown away in a sharps container. It's important to alternate injection sites between sides of the penis and apply firm pressure to the area for about five minutes afterward to prevent bruising or bleeding.
The active ingredient in Caverject is alprostadil.
Before using this medication, you may want to consult a healthcare provider about the following:
Prolonged erections can occur. Caverject may cause erections that last too long, including priapism, a painful erection lasting more than 4 hours. Seek immediate medical care if this happens to prevent permanent damage.
Scar tissue in the penis is possible. Some people may develop penile fibrosis, which can cause bending or hard tissue inside the penis. Your healthcare provider may check for this during follow-up visits and stop treatment if it develops.
Low blood pressure may occur. The medication can sometimes lower blood pressure, especially in people with certain blood flow conditions in the penis.
Bleeding at the injection site may happen. This risk is higher if you take blood thinners such as warfarin or heparin. Press on the injection site with gauze or an alcohol swab for several minutes after injecting.
Erectile dysfunction can sometimes be related to underlying cardiovascular problems, so your healthcare provider may evaluate and treat those conditions first.
Do not combine with other injected ED medications. Using Caverject with other injectable erectile dysfunction drugs is not recommended because safety has not been well studied.
Rare needle problems can occur. The injection uses a very fine needle, and in rare cases the needle may break if used incorrectly. Follow injection instructions carefully to reduce this risk.
Not for infants or children. Caverject contains benzyl alcohol and is not approved for use in newborns or infants.
Does not protect against sexually transmitted infections. You should still use protection, such as condoms, to reduce the risk of sexually transmitted diseases including HIV.
Avoid taking or using this medication if any of the following apply:
Common side effects of Caverject include:
These side effects usually occur where the medication is injected and are often mild. Some people may notice temporary redness, bruising, or irritation at the injection site. Following proper injection instructions can help reduce these effects.
More serious side effects are less common but possible. Caverject can cause priapism, which is an erection that lasts longer than 4 hours and requires emergency medical care. Other risks include penile fibrosis (changes in penis shape), low blood pressure, or increased strain on the heart during sexual activity. Seek medical help right away if you develop chest pain, severe dizziness, or an erection that does not go away.
What is Caverject Vial?
Caverject Vial contains alprostadil, a medicine injected into the penis to treat erectile dysfunction. It works by relaxing smooth muscle and increasing blood flow, which helps produce an erection.
What is Caverject used for?
It is mainly used to treat erectile dysfunction in adult men. In some settings, it may also be used by a clinician as part of diagnostic testing to help evaluate the cause of erectile dysfunction.
How is Caverject Vial given?
Caverject is given by intracavernosal injection, which means it is injected into the side of the penis. The vial must be prepared exactly as instructed, and patients should be trained by a healthcare professional before using it at home.
How quickly does it work and how long does it last?
The erection usually begins within about 5 to 20 minutes after injection. The duration can vary depending on the dose and the individual response.
How often can Caverject be used?
It should not be used more than 3 times per week, and there should be at least 24 hours between doses. The dose should be individualized by the prescriber to reduce the risk of prolonged erection or other complications.
What are the most common side effects?
Common side effects include penile pain, mild bleeding or bruising at the injection site, and prolonged erection. Some men may also develop fibrosis or scar-like changes in penile tissue with ongoing use.
What serious risks should patients know about?
The most important serious risk is priapism, which is an erection lasting too long and needing urgent treatment. Penile scarring, curvature, and low blood pressure or dizziness can also occur in some patients.
Who should not use Caverject Vial?
It should not be used in people who are allergic to alprostadil, who have conditions that increase the risk of priapism such as sickle cell disease, leukemia, or multiple myeloma, or who have penile conditions that make injection unsafe. It is also not meant for women or children.
Can Caverject be used with other erectile dysfunction treatments?
Patients should only combine it with other erectile dysfunction treatments if their prescriber specifically instructs them to do so. Using multiple erection treatments together may increase the risk of side effects, especially prolonged erection.
Are there any storage or handling points to remember?
The reconstituted vial is intended for single use only and should be discarded after use. Needles, syringes, and the vial should be disposed of safely, and patients using self-injection should be reviewed periodically by their prescriber, commonly every 3 months.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.